09/18/2014
https://congress.gov...
"Statement, dated February 7, 2012, of the Biotechnology Industry Organization, submitted by Mr. Pitts."
"A lot of folks where I come from, they can't afford a $50 substitute for a $20 product that they have been taking for way too many years."
"the strong risk aversion at the FDA is creating at least the perception that it is slowing down or stopping the approval of new, innovative treatments for cancer and other life-threatening terminal di..."
"Today, we will discuss reauthorizations of the Prescription Drug User Fee Act, PDUFA, the Best Pharmaceuticals for Children Act, BPCA, and the Pediatric Research Equity Act, PREA, all of which expire ..."